Literature DB >> 1988520

Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections.

A M Sugar1, M Picard.   

Abstract

Conidia, produced by the mycelial phase of dimorphic fungi, are thought to represent the infectious form of the organism but must complete a transition to the tissue-invasive, yeast-like phase for infection to ensue. Preventing such transition should effectively eliminate pathogenicity. Using Blastomyces dermatitidis as a target, murine bronchoalveolar macrophages preferentially blocked phase transition after 4 h of incubation with conidia, relatively sparing the ability of conidia to produce hyphae. H2O2, in relatively high concentrations, demonstrated the same activity. The effects of H2O2 seem irreversible, since H2O2-treated conidia that germinated at 48 h at 25 degrees C were still unable to produce yeasts over the next 5 days when incubated at 37 degrees C. Catalase could not reverse the macrophage-induced inhibition of phase transition, suggesting that nonoxidative defense mechanisms may be operative in vivo. Since conidia do not form mycelia at temperatures found in mammalian hosts, these effects may represent a novel host defense mechanism against dimorphic fungal pathogens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988520     DOI: 10.1093/infdis/163.2.371

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  The unappreciated intracellular lifestyle of Blastomyces dermatitidis.

Authors:  Alana K Sterkel; Robert Mettelman; Marcel Wüthrich; Bruce S Klein
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

3.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

Review 4.  Clinical and laboratory update on blastomycosis.

Authors:  Michael Saccente; Gail L Woods
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  SREB, a GATA transcription factor that directs disparate fates in Blastomyces dermatitidis including morphogenesis and siderophore biosynthesis.

Authors:  Gregory M Gauthier; Thomas D Sullivan; Sergio S Gallardo; T Tristan Brandhorst; Amber J Vanden Wymelenberg; Christina A Cuomo; Garret Suen; Cameron R Currie; Bruce S Klein
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

6.  Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii.

Authors:  Judith N Steenbergen; Joshua D Nosanchuk; Stephanie D Malliaris; Arturo Casadevall
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

7.  N-acetylglucosamine (GlcNAc) triggers a rapid, temperature-responsive morphogenetic program in thermally dimorphic fungi.

Authors:  Sarah A Gilmore; Shamoon Naseem; James B Konopka; Anita Sil
Journal:  PLoS Genet       Date:  2013-09-19       Impact factor: 5.917

Review 8.  Applications of Invertebrate Animal Models to Dimorphic Fungal Infections.

Authors:  Junya L Singulani; Liliana Scorzoni; Haroldo C de Oliveira; Caroline M Marcos; Patricia A Assato; Ana Marisa Fusco-Almeida; Maria José S Mendes-Giannini
Journal:  J Fungi (Basel)       Date:  2018-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.